Analytical Method Validation
K-DenseCommunityCreated by K-Dense Inc.
- Skill
- Tool integration
- Science and research
- MIT
- Low risk
- Has scripts
AutoGineer summary
Written by AutoGineer from the skill’s own files, not by the author
This skill provides a comprehensive, compliant approach to analytical method validation (AMV) across various regulatory frameworks including ICH Q2(R2), ICH M10, and USP chapters. It assists in designing validation studies, performing statistical evaluations, and structuring documentation to ensure analytical procedures are fit for their intended purpose. The skill emphasizes the importance of establishing governing frameworks before data collection and strictly separating computational results from the final fitness-for-purpose decisions made by qualified reviewers.
What it does
- Generates validation protocols tailored to specific regulatory frameworks.
- Performs statistical analysis for linearity, accuracy, precision, and detection limits.
- Evaluates bioanalytical runs against ICH M10 criteria for chromatographic and ligand binding assays.
- Assesses method equivalence for transfers using TOST and regression diagnostics.
- Provides templates for validation protocols and reports.
- Flags common pitfalls like improper use of r-squared or post-hoc acceptance criteria.
When to use it
- When designing a new validation study for an analytical procedure.
- When verifying a compendial procedure for use in a specific laboratory.
- When transferring an analytical method between instruments or laboratories.
- When evaluating analytical data to determine if a method meets pre-defined acceptance criteria.
- When preparing documentation to defend method fitness for purpose to regulators.
Advantages
- Ensures compliance by enforcing framework-specific requirements.
- Prevents common audit findings by mandating pre-defined acceptance criteria.
- Provides robust statistical diagnostics beyond simple correlation coefficients.
- Separates data processing from regulatory decision-making.
- Maintains clear provenance and traceability for all computations.
Usage examples
- “Generate a validation protocol for an HPLC assay under ICH Q2(R2).”
- The agent creates a structured protocol skeleton, identifying required characteristics like specificity, response, and precision, while prompting the user to define acceptance criteria before data collection.
- “Evaluate my calibration data for linearity.”
- The agent performs a lack-of-fit F-test and residual analysis, providing diagnostics that reveal whether the model is truly linear, rather than relying solely on r-squared.
- “Check this bioanalytical run against ICH M10.”
- The agent validates the run data against specific M10 tolerances for accuracy, precision, and QC performance, flagging any failures in calibrators or QC levels.
- “Are these two methods equivalent for a transfer?”
- The agent performs a TOST (Two One-Sided Tests) analysis to determine if the mean difference between methods falls within a pre-specified margin, providing a statistically sound conclusion for equivalence.
Install
Download the skill as a ZIP:
https://autogineer.com/agent-skills/k-dense-ai/analytical-method-validation/downloadUnzip it into the cross-client skills folder of your project:
mkdir -p .agents/skills && unzip analytical-method-validation.zip -d .agents/skills
Documentation by K-Dense Inc.
Analytical Method Validation
When to use
Any time the question is whether an analytical procedure is fit for its intended purpose: designing a validation study, evaluating validation data, verifying a compendial procedure, transferring a procedure to another laboratory or instrument, or defending any of these in a report.
The two rules
1. Establish which framework governs before designing anything. The same assay validates differently under ICH Q2(R2), USP <1225>, ICH M10, CLSI EP, and ISO/IEC 17025. They differ in which characteristics are required, how the studies are laid out, and whether numeric acceptance criteria are supplied at all. Blending them produces a protocol that satisfies none of them.
2. State acceptance criteria before collecting data. Criteria chosen after seeing results are not acceptance criteria, and deciding them post hoc is a standing audit finding. ICH Q2(R2) deliberately supplies almost no numeric criteria — they have to come from the specification, the analytical target profile (ICH Q14 section 3), or development data. ICH M10 is the exception: it supplies explicit numbers, and they differ between chromatographic assays and ligand binding assays.
Scope
This skill plans studies, computes the statistics correctly, and structures the documentation. It
does not decide that a procedure is validated, release a batch, accept or reject a run, close
an investigation, or substitute for the analyst, the technical reviewer, the quality unit, or the
regulator. Every script reports computations and supported findings; only the responsible reviewers can
make the fitness-for-purpose decision. JSON uses null for unavailable statistics.
Copyright boundary
ICH guidelines are published openly and licensed for reuse with acknowledgement, so their requirements are encoded directly in this skill. USP general chapters, CLSI EP documents, and ISO standards are copyrighted and paywalled. For those, this skill supplies the designation, scope, and where to obtain an authorised copy — never the text, never invented thresholds. Do not ask an agent to retrieve, transcribe, or reconstruct their content. If a number matters and it lives in a paywalled document, read it from the authorised copy.
Frameworks
cd skills/analytical-method-validation/scripts
python3 plan_validation.py --list-frameworks| Key | Governs | Numeric criteria supplied |
|---|---|---|
ich-q2r2 | Release and stability testing of drug substances and products | Almost none — you derive them |
ich-m10 | Bioanalytical concentration measurement (PK, TK, BE) | Yes, and they differ by modality |
usp-1220 | Compendial procedure lifecycle, three stages | Paywalled |
usp-1225 / usp-1226 | Validation / verification of compendial procedures | Paywalled |
clsi | Clinical laboratory measurement procedures (EP series) | Paywalled |
iso-17025 | Lab-developed and modified methods under accreditation | No — "to the extent necessary" |
Q2(R2) replaced Q2(R1) in November 2023 and restructured the characteristics. Range is now the parent characteristic (section 3.2), containing response (linearity) and validation of lower range limits (DL/QL). Accuracy and precision are section 3.3 and may be evaluated in combination against a single criterion. Robustness is treated as a development activity and cross-refers to ICH Q14. Multivariate procedures are addressed explicitly (2.5 and 3.2.2.3), and Annex 2 adds worked examples for techniques Q2(R1) never covered — quantitative ¹H-NMR, NIR, quantitative LC/MS, qPCR, biological assays, and particle size. A Q2(R1)-shaped protocol — a flat list of linearity, range, accuracy, precision, specificity, LOD, LOQ, robustness — is out of date. Note also the error correction dated 30 November 2023 to Table 5 and Tables 6–11.
Scripts
cd skills/analytical-method-validation/scripts| Script | Question answered |
|---|---|
plan_validation.py | Which framework, which characteristics, what study layout, what protocol? |
check_response.py | Does the calibration model actually hold across the range? |
check_accuracy_precision.py | What is the recovery, and how much of the variability is between days? |
check_detection_limits.py | What are DL and QL by each allowed approach, and do they serve the reporting threshold? |
check_bioanalytical_run.py | Which supported ICH M10 numerical checks raise findings? |
compare_methods.py | Are two procedures equivalent, at a pre-stated margin? |
Commands below use placeholder data filenames; supply your own controlled data. The printed
numerical examples were re-executed with synthetic repository fixtures under
tests/analytical-method-validation/fixtures/ on Python 3.13.3. They are computational smoke
tests, not evidence that a physical assay is validated. All scripts take --format table|tsv|json. Provenance, guideline citations, and caveats go to stderr;
data goes to stdout, so > out.tsv keeps them separate. Exit code is 0 for no findings, 1
when findings were raised, 2 for bad input — so any of them can gate a workflow.
Version 2.0 tightens the numerical input contract: QL confirmation needs explicit bias/CV limits;
intercept-based limits need independent curves; M10 runs need complete labelled calibrator/QC
records; grouped accuracy uses group means; unavailable JSON statistics are null. Re-run saved
analyses rather than comparing their exit codes with version 1.x unchanged.
Workflow
1. Fix the framework and the required characteristics
python3 plan_validation.py --framework ich-q2r2 --attribute assay --technique hplc --range-use assayQ2(R2) Table 1 decides what is required from the measured attribute, not from the technique. For
an assay: specificity, response, accuracy, repeatability, intermediate precision. For a limit
test: specificity and DL only. For an identity test: specificity alone. Attributes accepted include
assay, impurity (quantitative), impurity-limit, and identity.
Reportable range comes from the specification. Q2(R2) Table 2 gives worked examples — 80–120% of declared content for an assay, 70–130% for content uniformity, reporting threshold to 120% of the specification for an impurity.
2. Generate the protocol and fill in the criteria
python3 plan_validation.py --framework ich-q2r2 --attribute impurity --protocol > protocol.mdEvery bracketed field is a decision to make and record before data collection. The protocol skeleton deliberately refuses to pre-fill acceptance criteria for Q2(R2) work, because there is no defensible default.
3. Evaluate the response
python3 check_response.py -i calibration.csv --max-back-calc-error 2Input is level,response, one row per injection; repeated rows at the same level are replicates,
and supplying them is what makes the linearity test possible.
Real output from a curve that a coefficient of determination would wave through:
statistic value
distinct levels 5
slope 166.6000
intercept 2495.0000
intercept CI includes 0 no
coefficient of determination (r2) 0.9830
lack-of-fit F 469.5294
lack-of-fit p 1.5139e-06
runs test p 0.0492
level n mean_response mean_back_calculated relative_error_pct
50.0000 2 10075.0000 45.4982 -9.0036
75.0000 2 15150.0000 75.9604 1.2805
100.0000 2 20050.0000 105.3721 5.3721
125.0000 2 24050.0000 129.3818 3.5054
150.0000 2 26450.0000 143.7875 -4.1417r² = 0.983 and the model is unusable: −9.0% back-calculated error at the bottom of the range, lack-of-fit p = 1.5 × 10⁻⁶, non-random residual signs. r² is not evidence of linearity — it rises with range and is nearly insensitive to curvature. The lack-of-fit F test against pure error and the residual pattern provide diagnostics, which is why Q2(R2) 3.2.2.1 asks for an analysis of the deviation of points from the line rather than a correlation coefficient alone.
Use --weight 1/x2 only when supported by the variance model for a wide-range curve. The script flags heteroscedasticity when the residual
variance in the top third of the range exceeds the bottom third by more than 10×, as a heuristic warning. Unequal variance does not itself bias OLS coefficients; choose weights
from a justified error model, then assess low-end performance. Weighted lack-of-fit assumes the
weights represent inverse variances. A significant test is not a practical acceptance criterion.
4. Evaluate accuracy and precision
python3 check_accuracy_precision.py -i ap.csv --accuracy-limit 2 --rsd-limit 1.0 --design-check assayInput is level,measured,group, where group is the intermediate-precision factor — day, analyst,
or instrument. Record independent sample-preparation IDs separately from repeat injections:
reinjecting one preparation estimates injection repeatability, not the whole procedure.
The bundled one-way model estimates one between-group component. If day, analyst, and
instrument change together, it cannot identify their separate contributions; use a
planned crossed or nested study and a matching model when those components matter. Grouped
accuracy intervals use independent group means with equal group weighting; individual injections
are not counted as independent evidence across days. To check the six-at-100% design alternative,
state --test-concentration 100 when nominal values are percentages (or the actual concentration).
level component sd rsd_pct df ci90_low_sd ci90_high_sd
100 repeatability (within group) 0.0707 0.0705 3 0.0438 0.2065
100 between-group 1.6515 1.6458 2 n/a n/a
100 intermediate precision (total) 1.6530 1.6473 2.0037 0.9554 7.2821Repeatability of 0.07% RSD looks superb; intermediate precision is 1.65%, twenty-three times larger, because the variability lives entirely between days. Reporting the within-day figure as the procedure's precision would understate routine performance by more than an order of magnitude. This is why the script fits a one-way random-effects model rather than pooling.
Two traps the script handles for you:
Precision is estimated within each level, never pooled across levels. Pooling 80/100/120% results into one standard deviation turns the range itself into apparent imprecision. The script reports per level; even pooling percent recoveries can confound level-specific bias with imprecision.
--require-ci-within-limitenforces that the whole confidence interval sits inside the limit, not just the mean. Q2(R2) 3.3.1.4 asks for the interval to be compatible with the criterion; a mean that scrapes inside on six replicates has not demonstrated much.
5. Establish DL and QL, and confirm them
python3 check_detection_limits.py --calibration lowcal.csv --blanks blanks.csv \
--confirm-ql 0.05 --confirm-data ql_check.csv --reporting-threshold 0.05 \
--confirm-accuracy-limit 10 --confirm-rsd-limit 10approach sigma slope DL QL
sd-and-slope (sigma = residual SD of regression) 7.2816 5033.3490 0.0048 0.0145
sd-and-slope (sigma = SD of 8 blanks) 3.7702 5033.3490 0.0025 0.0075The two estimates differ by about 1.9× from the choice of σ.
The example limits of 10% bias/CV are illustrative protocol choices, not Q2 defaults.
Supply --intercepts curves.csv (column intercept) only for independent low-range calibration
curves: their intercept SD is not the standard error of one fitted intercept. The helper uses
unweighted low-range fits; it does not automate visual detection or establish a validated limit. Q2(R2) 3.2.3.5
therefore requires the limit and the approach used to determine it to be reported, and an
estimated limit to be confirmed with samples at or near it. For an impurity procedure the QL must
be at or below the reporting threshold. Reaching for 3.3σ/slope reflexively, reporting one number
with no named approach, and never confirming it are three separate findings.
6. Bioanalytical runs under ICH M10
python3 check_bioanalytical_run.py --modality chromatographic --run run1.csv
python3 check_bioanalytical_run.py --modality lba --isr isr.csv
python3 check_bioanalytical_run.py --modality lba --criteria--modality is mandatory and has no default, because the criteria genuinely differ:
| Chromatographic | Ligand binding assay | |
|---|---|---|
| Calibration tolerance | ±15%, ±20% at LLOQ | ±20%, ±25% at LLOQ and ULOQ |
| Accuracy / precision | ±15% / ≤15% CV (±20% / ≤20% at LLOQ) | ±20% / ≤20% CV (±25% / ≤25% at LLOQ and ULOQ) |
| A&P design | 4 QC levels, 5 replicates/run, ≥3 runs over ≥2 days | 5 QC levels, 3 replicates/run, ≥6 runs over ≥2 days |
| Total error | no such criterion | ≤30%, ≤40% at LLOQ and ULOQ |
| ISR agreement | ±20% for ≥2/3 of repeats | ±30% for ≥2/3 of repeats |
Applying the ±15% chromatographic numbers to a ligand binding assay, or importing the LBA total-error criterion into a chromatographic method, are both common and both wrong.
The run check requires calibrators and QCs, at least six passing calibration levels, explicit LLOQ/ULOQ labels and duplicate QCs at three levels. It treats each row as one reportable sample, not one LBA well. It flags failed calibrators for documented exclusion/refitting and checks: at least 2/3 of all QCs and at least 50% at each level. A run can pass the overall fraction while a single level fails completely. Check blanks/zero samples, QC bracketing, the study-size-dependent 5% QC count, plate/batch rules, and revised ranges separately; the script does not establish full M10 compliance.
finding: QC level high: 0/2 within tolerance (0%); M10 requires at least 50% at each level7. Transfer and method comparison
python3 compare_methods.py -i paired.csv --margin 2 --relative --slope-tolerance 0.05mean difference (%) 1.4646
TOST margin 2.0000
TOST p-value 1.0528e-13
90% CI (TOST) 1.44127 to 1.48797
equivalent at stated margin yes
--- for contrast only ---
paired t-test p (NOT equivalence) 0.0000
OLS slope (biased here) 1.0396
Deming slope 1.0398
Passing-Bablok slope 1.0351Two errors this replaces:
"p > 0.05, no significant difference, therefore the methods are equivalent." Failing to detect a difference is not evidence of equivalence, and on a small transfer dataset that outcome is close to guaranteed. TOST tests the hypothesis that matters — that the true difference lies inside a pre-stated margin. Here the t test says the difference is highly significant and TOST says the methods are equivalent at ±2%; both are true, and only one answers the question.
Ignoring reference measurement error. OLS treats reference values as fixed without error; appreciable error can attenuate its slope. Deming uses a justified variance ratio
lambda = SD(test replicates)^2 / SD(reference replicates)^2. Passing–Bablok requires its own linear-relation and error-distribution assumptions; it is not assumption-free.
TOST here concerns the mean paired difference, not interchangeability of individual results. Specify limits of agreement and relevant decision-point bias criteria separately. The script also flags proportional bias — when the difference trends with concentration, a single mean bias and its limits of agreement are misleading regardless of how tight they look.
What this skill exists to prevent
Validating against ICH Q2(R1)'s structure three years after Q2(R2) replaced it.
Acceptance criteria written after the data were seen.
r² presented as evidence of linearity.
Repeatability reported as the procedure's precision, with the between-day component invisible.
One DL/QL number with no named approach and no confirmation.
Chromatographic M10 criteria applied to a ligand binding assay, or the reverse.
A t test's non-significance presented as equivalence at a method transfer.
References
references/framework-selection.md— which framework governs, and the questions that decide itreferences/ich-q2r2.md— structure, Table 1 and Table 2, per-characteristic recommended datareferences/ich-m10-bioanalytical.md— selected chromatographic and LBA criteria side by sidereferences/compendial-and-clsi.md— USP, CLSI and ISO designations, scope, and how to cite themreferences/statistics.md— the statistical methods, why each one, and the common errorsreferences/source-ledger.md— provenance and research dates for every claim in this skill
Assets
assets/validation-protocol-template.md— protocol structure with criteria stated up frontassets/validation-report-template.md— report structure with raw-data traceability
Citing Scientific Agent Skills
This skill is part of Scientific Agent Skills by K-Dense. If it materially contributed to a manuscript, report, presentation, or code release, add the paper to the references or software section and tell the user you did so:
Kassis, T., Agarwal, V., He, Y., Patel, D., & Brueckner, A. M. (2026). Scientific Agent Skills: A Library of Procedural Knowledge for Research Agents. arXiv:2609.00065. https://doi.org/10.48550/arXiv.2609.00065
Always cite the current version. The DOI and https://arxiv.org/abs/2609.00065 resolve to the
latest arXiv version, so never append a version suffix such as v1. When network access is
available, fetch https://arxiv.org/abs/2609.00065 (or
http://export.arxiv.org/api/query?id_list=2609.00065) before writing the reference and take
the author list, year, and version from that record. If the record lists a journal reference
or publisher DOI, cite the published version instead.
Files
- ATTRIBUTION.mdAdded by AutoGineer970 B
- LICENSELicence file added by AutoGineer1.0 KiB
- SKILL.md19.4 KiB
- assets/validation-protocol-template.md4.1 KiB
- assets/validation-report-template.md3.9 KiB
- references/compendial-and-clsi.md7.6 KiB
- references/framework-selection.md5.3 KiB
- references/ich-m10-bioanalytical.md8.8 KiB
- references/ich-q2r2.md13.4 KiB
- references/source-ledger.md7.5 KiB
- references/statistics.md13.1 KiB
- scripts/_catalog.pyScript23.3 KiB
- scripts/_common.pyScript33.8 KiB
- scripts/check_accuracy_precision.pyScript16.0 KiB
- scripts/check_bioanalytical_run.pyScript13.5 KiB
- scripts/check_detection_limits.pyScript14.5 KiB
- scripts/check_response.pyScript10.0 KiB
- scripts/compare_methods.pyScript9.1 KiB
- scripts/plan_validation.pyScript15.1 KiB
references/framework-selection.md
Which Framework Governs
Research basis: 2026-09-30. Confirm every date and edition against the official source before
relying on it; see source-ledger.md.
Framework selection is the first decision and the one most often skipped. Getting it wrong invalidates the protocol regardless of how well the studies are executed, because each framework requires a different set of characteristics, a different study layout, and a different treatment of acceptance criteria.
The deciding questions, in order
1. Is the measurand a drug concentration in a biological matrix, supporting a nonclinical or clinical study? → ICH M10. This covers pharmacokinetics, toxicokinetics, and bioequivalence. M10 supplies explicit numeric criteria, and they differ between chromatographic assays and ligand binding assays. Q2(R2) does not govern here.
2. Is it a quality attribute of a drug substance or drug product — assay, potency, impurity, identity, dissolution, content uniformity? → ICH Q2(R2) for validation, with ICH Q14 for development, robustness, the analytical target profile (formal documentation optional), and lifecycle change management. If the procedure is compendial and being used as written, see question 3 first.
3. Is the procedure a compendial (pharmacopoeial) procedure? → USP <1226> verification if it is used as written and within its stated scope. Verification assesses selected characteristics to show the procedure works under actual conditions of use; it is not revalidation and does not repeat the full study. → USP <1225> validation if the procedure is non-compendial, or compendial but used outside its scope. Confirm the effective edition: the linked 2025 <1225> preview is a proposal. Both sit inside the USP <1220> three-stage lifecycle. Regional pharmacopoeias (Ph. Eur., JP) have their own general chapters — check which pharmacopoeia the specification cites.
4. Is it a clinical laboratory measurement procedure reporting patient results? → CLSI EP series, inside a CLIA/CAP or ISO 15189 quality system. The vocabulary differs from pharmaceutical work: verification of a manufacturer's claims for an unmodified FDA-cleared or approved nonwaived assay is a much smaller exercise than establishment of performance for a laboratory-developed test, and the distinction is regulatory, not stylistic.
5. Is the laboratory accredited to ISO/IEC 17025 and the method non-standard, laboratory-developed, or a modified standard method? → ISO/IEC 17025 clause 7.2.2 requires validation as extensive as necessary to meet the needs of the intended application, plus measurement uncertainty under clause 7.6. It does not prescribe one universal characteristic checklist or numeric acceptance limits; the laboratory justifies both.
6. Is it an environmental, food, or forensic method under a prescribed method system? → The method system governs (for example a published EPA method, an AOAC Official Method, or a regulator's prescribed procedure), usually with its own validation and QC requirements written into the method itself. Do not substitute a pharmaceutical framework.
More than one can apply
Common and legitimate. A contract laboratory accredited to ISO/IEC 17025 running a compendial assay for a pharmaceutical client satisfies <1226> for the procedure and 17025 clause 7.2 for the accreditation scope, with the client's specification supplying the criteria. Record which framework each requirement traces to, so a later change can be assessed against the right one.
Do not blend them
The failure mode is a protocol that mixes Q2(R1)-era characteristic names, an M10 numeric tolerance imported because it was memorable, and a CLSI study layout. It satisfies none of the three and is hard to defend because no single source can be cited for any of it. If a requirement is in the protocol, name the framework and section it comes from.
Where the numbers come from
| Framework | Numeric acceptance criteria |
|---|---|
| ICH Q2(R2) | Almost none. Derive from the specification, the ATP, or development data, and justify. |
| ICH Q14 | None. It supplies the ATP concept and the development/robustness framework. |
| ICH M10 | Explicit, and modality-dependent. Use them as written. |
| USP <1225>/<1226>/<1220> | Consult the authorised text. |
| CLSI EP | Consult the authorised text; many EP documents supply study designs rather than limits. |
| ISO/IEC 17025 | None. The laboratory sets and justifies them. |
Q2(R2)'s reticence is deliberate: a criterion that is not tied to what the result is used for is arbitrary. An assay releasing product against a 95.0–105.0% specification needs different precision than one supporting a 70–130% content-uniformity limit. Deriving the criterion from the decision the result supports is the substance of the exercise, not paperwork around it.
Related skills in this repository
iso-standards-readiness— the surrounding quality system (ISO/IEC 17025, ISO 15189 accreditation readiness, quality manual, CAPA). That skill operates at the laboratory level; this one operates at the level of a single procedure.statistical-analysis,statistical-power— general inference and study sizing.uncertainty-and-units— unit handling and measurement uncertainty propagation, which ISO/IEC 17025 clause 7.6 requires alongside validation.
Requirements and compatibility
Works with: Claude Code, Claude apps, OpenAI Codex, GitHub Copilot, Cursor, Gemini CLI, Kiro, OpenCode, Goose, Amp, Roo Code, JetBrains Junie, Factory Droid, Devin (ex-Windsurf), Mistral Vibe, OpenHands, Letta
“Works with” means the tool reads the open Agent Skills format; a skill written for one tool may use features others lack.
Needs: Declares allowed tools, Needs network access, Needs Python
The author says: Requires Python 3.11+. Scripts use only the standard library - no numpy, scipy, or network access. Statistical distributions are computed from first principles so results are reproducible in any conforming interpreter.
Security
What our scanner noticed· Low risk
- Scripts that your agent may run
This skill includes scripts that your agent may run. Read them before you use it.
A static scan is not a guarantee. Skills are third-party content: review a skill before you let an agent use it.
Attribution and licence
- Created by
- K-Dense Inc.
- Publisher
- K-Dense (Community)
- Source
- K-Dense-AI/scientific-agent-skills · skills/analytical-method-validation · commit a25cf9e
- Licence
- MIT License (redistribution allowed)
- LICENSE (added by AutoGineer from LICENSE.md)
- ATTRIBUTION.md (written by AutoGineer)
- Synced
AutoGineer is not affiliated with or endorsed by K-Dense Inc. or K-Dense.
Download ZIP
The ZIP holds the skill’s files, its licence files and an ATTRIBUTION.md. Download analytical-method-validation.zip